Gemelli Biotech
Biotechnology ResearchNorth Carolina, United States11-50 Employees
Gemelli Biotech is a biotechnology research company based in Raleigh, North Carolina, employing 11 to 50 people. It specializes in microbiome-driven non-invasive precision diagnostics designed to help clinicians detect validated biomarkers and treat gastrointestinal diseases, including small intestinal bacterial overgrowth (SIBO), intestinal methane overgrowth (IMO), excess hydrogen sulfide, and post-infectious irritable bowel syndrome. The company has developed tests such as trio-smart, a breath test that measures hydrogen, methane, and hydrogen sulfide after the consumption of lactulose or glucose to provide a more complete microbiome profile. It has pursued partnerships and licensing deals with medical and research organizations, including an exclusive license with Cedars-Sinai for blood test technology, and collaborations with Biomedica de Referencia in Mexico City and Advanced Medical German Co. in the Middle East. Historically, Gemelli Biotech has operated in Los Angeles and Raleigh, reflecting a cross-regional presence in its development and commercialization efforts.
1-888-653-2347 
support@leadiq.com 
